This Issue
- India's Road to Success
- Spotlight
-
India is establishing itself as a global leader for pharmaceutical research, and increasingly, commercialization.
- Access to Innovation
- commercialization
-
Ideally, pharmaceutical pricing provides an incentive for innovation and also makes quality medicines accessible to all. Achieving this delicate balance, however, is proving to be a difficult proposition.
- The State of Stents
- development
-
Drug-eluting stents have been under fire recently, but the medical community has yet to decide if the risks outweigh the rewards.
- Rethinking Informed Consent
- management
-
Cultural understanding, technology and pragmatism are helping create new approaches to clinical research subject enrollment.
- Choosing Words Wisely
- commercialization
-
Semiotics and the process of studying vocabulary has found a niche in the pharmaceutical industry.
- Change is Constant
- management
-
To fully optimize adaptive clinical trial design, the proper technological tools must be in place.
- Culture Shift
- development
-
Drug safety monitoring needs to begin early in the development process and continue throughout the product’s entire lifecycle.
MediaCast
- A New Gold Standard
- Mediacast
-
John Doyle, DrPH, practice leader for market access at Quintiles Consulting, discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.
Web Exclusives
- Ahead of the Curve
-
As a follow-on biologics pathway inches closer to reality, interested companies must consider biologics’ unique characteristics when preparing to enter the game.
- Unanswered Questions
-
As the number of asthma cases climb globally, researchers focus on early intervention and effective treatments.
Columns
- A New Gold Standard for Pricing
-
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
- Challenge Accepted
-
Kathleen Marley-Matts, managing director of Quintiles Medical Education, discusses the challenges and opportunities in providing objective CME programming.
Most Read
